top of page

surgiGRAFT Product Attributes


The surgiGRAFT suite of products includes amniotic tissue derived allografts intended for reconstruction, repair, or replacement of a patient’s tissue.


Chorion free and orientation neutral Hydrated Form: hydrophilic properties allow tissue to conform to the surface or surgical site


Dry Form: handling properties allow easy application for open surgical techniques


Ambient temperature storage: terminally sterilized with up to a 3-year shelf life


Flexible: naturally conforms to complex anatomies


Fully resorbable: may be applied directly over bone, tendon, nerves, and wounds

Available in a range of sizes for optimal coverage.

coding flyer 1.png
coding flyer 4.png

For reimbursement support, please email

Amniotic Tissue Allografts are regulated under the FDA’s Public Health Service Act Section 361 as a Human Cell, Tissue or Cellular or Tissue Based Product (HCTP).


Handled according to all FDA regulations for Current Good Tissue Practices, its manipulation and processing are kept to a minimum, ensuring the preservation of its innate properties that help to promote advanced healing.

FDA Tissue standards pic_edited_edited.png

FDA Tissue Standards 

bottom of page